Chemoembolization With Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of the Advanced Practitioner in Oncology

• Publication date

  2016-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.6004/JADPRO.2016.7.7.8PMID 29670812PMCID 5902156
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Survival outcomes in patients with advanced hepatocellular carcinoma treated with drug-eluting bead chemoembolization.

  2015cited by this paper
• Transarterial chemoembolization and sorafenib in patients with intermediate-stage hepatocellular carcinoma: time to enter routine clinical practice?

  2015cited by this paper
• Transarterial chemoembolization for primary liver malignancies and colorectal liver metastasis.

  2015influential reference
• Global cancer statistics, 2012

  2015cited by this paper
• Transarterial chemoembolization and sorafenib in hepatocellular carcinoma

  2014cited by this paper
• Transarterial chemoembolisation and radioembolisation for the treatment of primary liver cancer and secondary liver cancer: A review of the literature

  2014cited by this paper
• Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma

  2014cited by this paper
• Re‐evaluating transarterial chemoembolization for the treatment of Hepatocellular Carcinoma: Consensus recommendations and review by an International Expert Panel

  2014influential reference
• Clinical appraisal of the recently proposed Barcelona Clinic Liver Cancer stage B subclassification by survival analysis

  2014influential reference
• Metastatic melanoma to the liver: A contemporary and comprehensive review of surgical, systemic, and regional therapeutic options

  2014cited by this paper
• Survival, efficacy, and safety of small versus large doxorubicin drug-eluting beads TACE chemoembolization in patients with unresectable HCC.

  2014cited by this paper
• Safety and Effectiveness of Chemoembolization with Drug-Eluting Beads for Advanced-Stage Hepatocellular Carcinoma

  2014cited by this paper
• Treatment of Hepatocellular Carcinoma

  2014cited by this paper
• Transarterial therapies for primary liver tumors.

  2014cited by this paper
• DC Bead Transarterial Chemoembolization Is Effective in Hepatocellular Carcinoma Refractory to Conventional Transarteral Chemoembolization: A Pilot Study

  2013cited by this paper
• Safety and efficacy of drug-eluting bead chemoembolization for hepatocellular carcinoma: comparison of small-versus medium-size particles.

  2013cited by this paper
• Doxorubicin-loaded drug-eluting beads (DC Bead®) for use in transarterial chemoembolization: A stability assessment

  2013cited by this paper
• Chemoembolization of Hepatocellular Carcinoma with Hepasphere 30–60 μm. Safety and Efficacy Study

  2013cited by this paper
• Single HCC in Cirrhotic Patients: Liver Resection or Liver Transplantation? Long-term Outcome According to an Intention-to-treat Basis

  2013cited by this paper
• How I Do It: Triaging Patients with Hepatocellular Carcinoma

  2012cited by this paper
• Chemoembolization With Doxorubicin-Eluting Beads for Unresectable Hepatocellular Carcinoma: Five-Year Survival Analysis

  2012cited by this paper
• Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design.

  2012cited by this paper
• Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma.

  2012cited by this paper
• Current status of embolic agents for liver tumor embolization

  2012cited by this paper
• Heterogeneity of Patients with Intermediate (BCLC B) Hepatocellular Carcinoma: Proposal for a Subclassification to Facilitate Treatment Decisions

  2012influential reference
• Implications for Clinical Practice and Trial Design

  2012cited by this paper
• Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma.

  2011cited by this paper
• Transcatheter intraarterial therapies: rationale and overview.

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• A Randomized Phase II Study of Drug-Eluting Beads versus Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma

  2011cited by this paper
• Chemoembolization agents for cancer treatment.

  2011cited by this paper
• Doxorubicin-Loaded QuadraSphere Microspheres: Plasma Pharmacokinetics and Intratumoral Drug Concentration in an Animal Model of Liver Cancer

  2010cited by this paper
• Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects

  2010cited by this paper
• Prospective Randomized Comparison of Chemoembolization with Doxorubicin-Eluting Beads and Bland Embolization with BeadBlock for Hepatocellular Carcinoma

  2010cited by this paper
• Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC)

  2010cited by this paper
• Liver metastases of neuroendocrine carcinomas: interventional treatment via transarterial embolization, chemoembolization and thermal ablation.

  2009cited by this paper
• NCCN clinical practice guidelines in oncology: hepatobiliary cancers.

  2009cited by this paper
• Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study

  2009cited by this paper
• Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization

  2008cited by this paper
• Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization

  2008cited by this paper
• Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.

  2007cited by this paper
• Transarterial chemoembolization before liver transplantation in 60 patients with hepatocellular carcinoma.

  2007cited by this paper
• New Intra-arterial Drug Delivery System for the Treatment of Liver Cancer: Preclinical Assessment in a Rabbit Model of Liver Cancer

  2006cited by this paper
• Relation of hemochromatosis with hepatocellular carcinoma: epidemiology, natural history, pathophysiology, screening, treatment, and prevention.

  2005cited by this paper
• Arterial chemotherapy and transcatheter arterial embolization therapy for non-resectable hepatocellular carcinoma

  2004cited by this paper
• Global Epidemiology of Hepatitis B Virus

  2004influential reference
• Cancer Facts & Figures 2004

  2004cited by this paper
• Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome

  2003influential reference
• Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification

  1999cited by this paper
• A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients

  1998cited by this paper
• Treatment of hepatocellular carcinoma

  1997cited by this paper
• Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.

  1996cited by this paper
• In vivo and in vitro analysis of the effectiveness of doxorubicin combined with temporary arterial occlusion in liver tumors.

  1993cited by this paper
• Transcatheter oily chemoembolization of hepatocellular carcinoma.

  1989cited by this paper
• A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge

  1987cited by this paper
• Hepatic arterial chemotherapy and occlusion for palliation of primary hepatocellular and unknown primary neoplasms in the liver

  1983cited by this paper
• Non-operative arterial embolisation in primary liver tumours.

  1979cited by this paper

• X-ray Opaque Polymer Drug-Eluting Beads Loaded with Iodized Oil: Preparation and In Vitro and In Vivo Evaluations

  2024cites this paper
• CalliSpheres Drug-Eluting Bead Transcatheter Arterial Chemoembolization Presents With Better Efficacy and Equal Safety Compared to Conventional TACE in Treating Patients With Hepatocellular Carcinoma

  2019cites this paper